FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LN-1-255
异名/同义词4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3-((((3,4-DIHYDROXYPHENYL)ACETYL)OXY)METHYL)-3-METHYL-7-OXO-6-(2-PYRIDINYLMETHYLENE)-, 4,4-DIOXIDE, MONOSODIUM SALT, (2S,3R,5R,6Z)-
4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3-(((2-(3,4-DIHYDROXYPHENYL)ACETYL)OXY)METHYL)-3-METHYL-7-OXO-6-(2-PYRIDINYLMETHYLENE)-, 4,4-DIOXIDE, SODIUM SALT (1:1), (2S,3R,5R,6Z)-
LN-1-255
SODIUM (2S,3R,5R,6Z)-3-(((2-(3,4-DIHYDROXYPHENYL)ACETYL)OXY)METHYL)-3-METHYL-4,4,7-TRIOXO-6-((PYRIDIN-2-YL)METHYLIDENE)-4LAMBDA6-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE
CAS登记号247115-03-3
物质唯一标识(Unique Ingredient Identifier)RWF5DLZ74F
分子式C22H19N2O9S.Na
国际化合物标识(International Chemical Identifier,InChI)OISRDGHGSAOFKW-OIGABSMWSA-M
SMILESN12[C@H]([C@](S([C@@]2(/C(/C1=O)=C\c3ccccn3)[H])(=O)=O)(C)COC(=O)Cc4cc(c(cc4)O)O)C(=O)[O-].[Na+]
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2024 Drugfuture->FDA Global Substance Registration System